Category | Diagnostics

Ventana and Astellas in automated tissue diagnostics pact

Posted on 15 April 2015

Ventana Medical Systems has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics

Tags: , ,

Roche acquires Signature Diagnostics for access to translational oncology and genomics

Posted on 12 February 2015

Roche announced the acquisition of Signature Diagnostics

Tags: , ,

Personalis gains $33 million series C

Posted on 14 January 2015

Personalis has completed a $33 million Series C financing round

Tags: ,

Sera Prognostics gains series B financing for $20 million

Posted on 14 January 2015

Sera Prognostics has closed $20 Million in Series B financing

Tags: ,

CardioDx raises $35 million for COPD development

Posted on 20 December 2014

CardioDx announced the close of $35 million in total equity financing

Tags: ,

Philips acquires Volcano for $1.2 billion

Posted on 18 December 2014

Royal Philips and Volcano have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Volcano

Tags: , ,

Quotient BioDiagnostics pulls in $27 million financing

Posted on 27 November 2014

Quotient has entered into agreements to issue to certain subscribers 2,000,000 ordinary shares at $9.50 per share and 850,000 pre-funded warrants at $9.49 per warrant, exercisable for up to 850,000 ordinary shares at $0.01 per ordinary share

Tags: ,

Abbvie and Enterome partner on novel diagnostic products to support personalized therapies

Posted on 13 November 2014

ENTEROME Bioscience has entered into a collaborative development agreement with AbbVie

Tags: , , ,

Takeda and GE in hepatic fibrosis pact

Posted on 12 November 2014

GE Healthcare and Takeda Pharmaceutical have entered into an alliance agreement for research and development in the field of hepatic fibrosis

Tags: , , ,

Biolase have purchased $35 million in private financing

Posted on 06 November 2014

BIOLASE announced today that investors have agreed to purchase $35 million of unregistered shares of the Company’s common stock and warrants to purchase unregistered shares of the Company’s common stock in a private placement transaction.

Tags: ,